Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

Share Price is delayed by 15 minutes
Get Live Data
65.50    0.00 (0.00%)
Bid:
64.00
Ask:
67.00
Spread: 3.00 (4.688%)
Market Cap: £15.96m
MYX Live PriceLast checked at - London Stock Exchange

Intraday Mycelx Di Share Chart

Half Year Trading Update

7 Jul 2017 07:00

RNS Number : 3843K
MyCelx Technologies Corporation
07 July 2017
 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").This inside information is now considered to be in the public domain.

7 July 2017

MYCELX TECHNOLOGIES CORPORATION

("MYCELX" or the "Company")

Half Year Trading Update

 

Notification of Half Year Results

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for the Oil and Gas market and commercial industrial markets worldwide, is today providing a brief trading update ahead of its half year results, which will be announced on 13 September 2017.

MYCELX is pleased to confirm that H1 2017 revenues were in line with the Board's expectations. This follows an active first half of the year which, as previously announced, included the first contract award in the Nigerian Oil and Gas market, as well as a contract with a new SABIC affiliate customer. The Nigerian win represents the first conversion of several opportunities that MYCELX actively nurtured with customers last year with extended onsite trials alongside the operators. The addition of another SABIC affiliate customer builds on the strong footprint that we have developed in Saudi Arabia over the last seven years and reflects our focused business development efforts in the Middle East. The Board is also pleased with the progress of the global product launch of MYCELX RE-GEN currently underway with Schlumberger. The Company remains on track to meet current guidance of being operationally cash neutral for the full year ending 31 December 2017 and we look forward to providing further updates in relation to MYCELX's progress in due course.

 

Commenting on today's announcement, Connie Mixon, CEO, said:

"The Oil and Gas and petrochemical sectors have reset their cost structures and are cautiously investing in technology upgrades that support their future operational and business goals. Our contract wins in H1 illustrate the Company's successful initiatives to reach markets that greatly benefit from MYCELX's cost effective, advanced technology such as opening the market in Nigeria as well as further penetration in Saudi Arabia, a market we have operated in for over seven years. The Company remains committed to tight cost controls and will continue to allocate resources to sales and engineering in support of achieving our revenue goals in 2017 and beyond."

 

For further information please contact: 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

Tel: +1 888 306 6843

Cantor Fitzgerald Europe - NOMAD and Broker

Andrew Craig

Richard Salmond

 

 

Tel: +44 20 7894 7000

Celicourt Communications

Mark Antelme

Joanna Boon

 

Tel: +44 20 7520 9266

 

Notes to Editors

MYCELX is a revolutionary oil-free water technology company solving the world's toughest oil removal problems in the oil and gas industry. The systems are based upon scientific breakthrough for a completely different approach to permanent oil removal. The Company created the patented MYCELX polymer using innovative molecular cohesion for removing oil from water far beyond what conventional systems have ever achieved. MYCELX systems remove oil to critically low levels in a much smaller physical footprint than conventional systems and in a virtually fail-safe process.

www.mycelx.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTOKADPABKDDOK
Date   Source Headline
19th May 20217:00 amRNSInvestor Presentation
14th May 20217:00 amRNSPFAS System Validation
13th Apr 20211:49 pmRNSGrant of Options
23rd Mar 20217:00 amRNSBoard Changes
17th Mar 20213:37 pmRNSHolding(s) in Company
17th Mar 20212:35 pmRNSHolding(s) in Company
15th Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSTrading Update
18th Feb 20217:00 amRNSSale of MYCELX property in Duluth, USA
17th Feb 20214:32 pmRNSHolding(s) in Company
5th Jan 20212:32 pmRNSHolding(s) in Company
4th Jan 20217:00 amRNSHolding(s) in Company
27th Oct 20202:55 pmRNSResult of Annual Meeting
2nd Oct 20202:56 pmRNSNotice of Annual Meeting
22nd Sep 20207:00 amRNSHalf Year Results Statement
4th Sep 20207:00 amRNSAppointment of Nominated Adviser and Sole Broker
7th Aug 202011:50 amRNSDirector/PDMR Shareholding
22nd Jun 20207:00 amRNSContract extension with SABIC
19th Jun 20207:00 amRNSAnnual Financial Report
27th May 20207:00 amRNSFinal Results for the year ending 31 December 2019
11th May 20207:00 amRNSNew Project Award
14th Apr 20207:00 amRNSTrading Update
9th Mar 20207:00 amRNSClosure of Restricted Stock Line
5th Mar 20207:00 amRNSTrading Update
13th Dec 201910:25 amRNSBlock listing Interim Review
4th Nov 20197:00 amRNSTrading Update
16th Sep 20197:00 amRNSHalf Year Results Statement
20th Aug 201912:42 pmRNSHolding(s) in Company
16th Aug 20193:02 pmRNSDirector Shareholding
29th Jul 20197:00 amRNSDirectorate Changes
26th Jul 20197:00 amRNSAppointment of Nominated Adviser & Broker
22nd Jul 20191:34 pmRNSHolding(s) in Company
10th Jul 201912:57 pmRNSResult of Annual Meeting
14th Jun 20197:00 amRNSTrading Update
11th Jun 20197:00 amRNSBlock listing Interim Review
6th Jun 20197:00 amRNSIssue of Equity
31st May 20191:57 pmRNSAnnual Financial Report
13th May 20197:00 amRNSFinal Results for the year ending 31 December 2018
28th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
13th Mar 20197:00 amRNSIssue of Equity
28th Feb 20194:54 pmRNSResults of Fundraising
28th Feb 20197:00 amRNSProposed $1.8 million Placing
13th Feb 201910:22 amRNSTrading Update
21st Dec 20187:00 amRNSHolding(s) in Company
11th Dec 20187:15 amRNSDirectorate Changes
7th Dec 20187:00 amRNSBlock Admission Interim Update
29th Nov 20187:00 amRNSNew Project Award and Trading Update
8th Oct 20187:00 amRNSNew Project Award and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.